-
1
-
-
0000197190
-
Clinicopathologiccharacteristics and prognostic factors in 10783 patients with gastric cancer [J]
-
Kim J P, Lee J H, Kim S J, et al. Clinicopathologiccharacteristics and prognostic factors in 10783 patients with gastric cancer [J]. Gastric Cancer, 1998, 1(2): 125-133.
-
(1998)
Gastric Cancer
, vol.1
, Issue.2
, pp. 125-133
-
-
Kim, J.P.1
Lee, J.H.2
Kim, S.J.3
-
2
-
-
14744301259
-
Prognostic indicators in locally advanced gastric cancer (LAGC) treated with preoperative chemotherapy and D2-gastrectomy[J]
-
Persiani R, D'Ugo D, Rausei S. Prognostic indicators in locally advanced gastric cancer (LAGC) treated with preoperative chemotherapy and D2-gastrectomy[J]. J Surg Oncol, 2005, 89 (4): 227-236.
-
(2005)
J Surg Oncol
, vol.89
, Issue.4
, pp. 227-236
-
-
Persiani, R.1
D'Ugo, D.2
Rausei, S.3
-
3
-
-
0032836612
-
Borrmann's IV type gastric cancer: Clinicopathologic analysis [J]
-
Tokota T, Teshiman S, Saito T. Borrmann's IV type gastric cancer: clinicopathologic analysis [J]. Cancer J surg, 1999, 42 (5): 371-376.
-
(1999)
Cancer J surg
, vol.42
, Issue.5
, pp. 371-376
-
-
Tokota, T.1
Teshiman, S.2
Saito, T.3
-
4
-
-
0002763181
-
Treatment of peritoneal dissemination of gastric cancer with sequential methotrexate and 5-fluorouracil[J]
-
Konishi T, Noie T, Yoshida J, et al. Treatment of peritoneal dissemination of gastric cancer with sequential methotrexate and 5-fluorouracil[J]. Gastric Cancer, 1999, 2(1): 52-56.
-
(1999)
Gastric Cancer
, vol.2
, Issue.1
, pp. 52-56
-
-
Konishi, T.1
Noie, T.2
Yoshida, J.3
-
5
-
-
0034811794
-
Resent advances in the treatment of gastric cancer[J]
-
Sun W, Haller D G. Resent advances in the treatment of gastric cancer[J]. Drug, 2001, 11(61): 1545-1551.
-
(2001)
Drug
, vol.11
, Issue.61
, pp. 1545-1551
-
-
Sun, W.1
Haller, D.G.2
-
6
-
-
0033155723
-
Palliative superselective intraarterial chemotherapy for advanced nonresectable gastric cancer[J]
-
Shchepotin I B, Chorny V, Hanfelt J, et al. Palliative superselective intraarterial chemotherapy for advanced nonresectable gastric cancer[J]. J Gastrointest Surg, 1999, 3(4): 426-431.
-
(1999)
J Gastrointest Surg
, vol.3
, Issue.4
, pp. 426-431
-
-
Shchepotin, I.B.1
Chorny, V.2
Hanfelt, J.3
-
7
-
-
77953441397
-
-
Chinese source.
-
Chinese source.
-
-
-
-
8
-
-
0033758526
-
A phase II study of weekly docetaxel as salvage chemotherapy for advanced gastric cancer[J]
-
Graziano F, Catalano V, Baldelli A M, et al. A phase II study of weekly docetaxel as salvage chemotherapy for advanced gastric cancer[J]. Ann Oncol, 2000, 11(10): 1263-1266.
-
(2000)
Ann Oncol
, vol.11
, Issue.10
, pp. 1263-1266
-
-
Graziano, F.1
Catalano, V.2
Baldelli, A.M.3
-
9
-
-
0035987101
-
Phase II study of weekly paclitaxel plus 24 h continuous infusion 5-fluorouracil, folinic acid and 3-weekly cisplatin for the treatment of patients with advanced gastric cancer [J]
-
Honecker F, Kollmannsburger C, Quietzsch D, et al. Phase II study of weekly paclitaxel plus 24 h continuous infusion 5-fluorouracil, folinic acid and 3-weekly cisplatin for the treatment of patients with advanced gastric cancer [J]. Anticancer Drugs, 2002, 13(5): 497-503.
-
(2002)
Anticancer Drugs
, vol.13
, Issue.5
, pp. 497-503
-
-
Honecker, F.1
Kollmannsburger, C.2
Quietzsch, D.3
-
10
-
-
0033931245
-
A phase II study of paclitaxel, weekly, 24 h continuous infusion 5-fluorouracil, folinic acid and cisplatin in patients with advanced gastric cancer[J]
-
Kollmannsberger C, Quietzsch D, Haag C, et al. A phase II study of paclitaxel, weekly, 24 h continuous infusion 5-fluorouracil, folinic acid and cisplatin in patients with advanced gastric cancer[J]. Br J Cancer, 2000, 83(4): 458-462.
-
(2000)
Br J Cancer
, vol.83
, Issue.4
, pp. 458-462
-
-
Kollmannsberger, C.1
Quietzsch, D.2
Haag, C.3
|